Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Laboratories scientist Dr. Ankur Mutreja awarded prestigious - “DBT Cambridge Lectureship”

Date: 23/06/2016

Hilleman Laboratories scientist Dr. Ankur Mutreja awarded prestigious - “DBT Cambridge Lectureship”

New Delhi, 23rd June 2016: Recognising an exemplary achievement by one of its scientists, Hilleman Laboratories, a first-of- its-kind joint-venture partnership between MSD and the Wellcome Trust, proudly announces Dr. Ankur Mutreja’s appointment at the University of Cambridge under the prestigious “DBT Cambridge Lectureship” programme. In partnership with the Government of India’s (GoI’s) Department of Biotechnology (DBT), the University invited applications for 5 fixed-term, research-oriented University Lectureships to strengthen the University’s strategic relationship with Indian research institutions and enhance academic, research and translational capacities of India and UK.

Dr. Mutreja, who has been with Hilleman Laboratories, leading the company’s ETEC vaccine project is elated on being awarded this highly coveted role. Expressing his views, Dr. Ankur Mutreja, Project Lead Hilleman Laboratories said, “I am humbled to receive this honour and grateful to the University of Cambridge and the Department of Biotechnology, GoI for considering me for this prestigious position. I would also like to express my gratitude to Hilleman Laboratories for providing me a stimulating and highly motivating environment to enhance my knowledge and expertise through advanced research. I look forward to my continued association with the organisation.”

This development is a testimony to Hilleman Laboratories philosophy of providing world-class infrastructure and environment that nurtures talent, especially in the field of biotechnology and Vaccine R&D. Commenting on Dr. Mutreja’s achievement, Dr. Davinder Gill, CEO, Hilleman Laboratories said, “We are very proud of Dr. Mutreja’s accomplishment and extend our support through his five year stint at the University of Cambridge.” Highlighting this as a significant opportunity for Hilleman Laboratories, Dr. Gill added, “This presents a unique engagement platform wherein we aim to foster strategic alliances across UK and Europe.”

Dr Mutreja is one of the 5 scientists who have been selected for this lectureship programme. During the 5 years of the lectureship position, Dr. Mutreja will be dividing his time working with both UK and Indian institutions. In his latest capacity, Dr. Mutreja will further strategic ties for Hilleman Laboratories in the UK and European markets and facilitate the organisation’s application for grant funding.

About Hilleman Laboratories

Hilleman Laboratories is a first-of-its-kind joint-venture partnership formed between MSD a global research-driven pharmaceutical organization and Wellcome Trust, a global charitable foundation dedicated to human and animal health by supporting the brightest minds. Hilleman Laboratories has been named after renowned scientist and father of modern vaccines Dr. Maurice Hilleman. His dedication to making a difference through the practical application of Draft not for circulation vaccine research and delivering vaccines to people in need forms the core mission of Hilleman Laboratories.

Hilleman Laboratories aims to become a global voice for vaccine development and access for public health in the developing world. For further information please visit:

About University of Cambridge

The University of Cambridge is one of the world's oldest universities and leading academic centres, and a self-governed community of scholars. Based in the UK, its reputation for outstanding academic achievement is known world-wide and reflects the intellectual achievement of its students, as well as the world-class original research carried out by the staff of the University and the Colleges. Its reputation is endorsed by the Quality Assurance Agency and by other external reviewers of learning and teaching. These high standards are the result of both the learning opportunities offered at Cambridge and by its extensive resources, including libraries, museums and other collections. Teaching consists not only of lectures, seminars and practical classes led by people who are world experts in their field, but also more personalised teaching arranged through the Colleges.

View All